AGP
PFE icon

Aspire Growth Partners’s Pfizer PFE Stock Holding History

Aspire Growth Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$494K Sell
17,592
-1,496
-8% -$39.8K 0.34% 66
2025
Q4 		$475K Sell
19,088
-1,448
-7% -$36.5K 0.33% 71
2025
Q3 		$523K Sell
20,536
-2,398
-10% -$59.2K 0.38% 62
2025
Q2 		$556K Buy
22,934
+601
+3% +$14K 0.46% 53
2025
Q1 		$509K Hold
22,333
– – 0.45% 60
2024
Q4 		$592K Buy
+22,333
New +$606K 0.58% 44

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Aspire Growth Partners's PFE Position: Q1 2026 in Review

Aspire Growth Partners reduced its Pfizer (PFE) stake by 7.8% in Q1 2026, selling an estimated $39.8K and leaving 17,592 shares worth $494K. The position accounts for 0.34% of the portfolio, ranked #66.

Aspire Growth Partners first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $592K in Q4 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Aspire Growth Partners held 17,592 shares of Pfizer worth $494K as of Q1 2026.
  • Aspire Growth Partners sold 1,496 Pfizer shares in Q1 2026, an estimated $39.8K.
  • Pfizer made up 0.34% of Aspire Growth Partners's portfolio in Q1 2026, its #66 holding.
  • Aspire Growth Partners first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Aspire Growth Partners's Pfizer position peaked at $592K in Q4 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Aspire Growth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.